William Benton Jones, See Remarks at Corvus Pharmaceuticals, Inc. (CRVS), bought 20,000 shares at $1.73 ($35K) on 2024-05-06, disclosed to the SEC on 2024-05-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.